MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma

Hodgkin Lymphoma Cell Lines Are Characterized by a Specific miRNA Expression Profile

(2015) Johan H. Gibcus et al.   NEOPLASIA

Downregulation of miR-21 Enhances Chemotherapeutic Effect of Taxol in Breast Carcinoma Cells

(2014) Mei Mei et al.   TECHNOLOGY IN CANCER RESEARCH & TREATMENT

Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma

(2012) E. Tiacci et al.   BLOOD

Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets

(2011) A. J. Arribas et al.   BLOOD

A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era

(2011) A. M. Evens et al.   BLOOD

miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy

(2011) S. Montes-Moreno et al.   BLOOD

MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response

(2011) W. Wang et al.   HAEMATOLOGICA

Stage IV and age over 45 years are the only prognostic factors of the International Prognostic Score for the outcome of advanced Hodgkin lymphoma in the Spanish Hodgkin Lymphoma Study Group series

(2011) Pablo Guisado-Vasco et al.   LEUKEMIA & LYMPHOMA

MiRNAs and Their Association with Locoregional Staging and Survival Following Surgery for Esophageal Carcinoma

(2010) Richard Hummel et al.   ANNALS OF SURGICAL ONCOLOGY

A molecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma

(2010) B. Sanchez-Espiridion et al.   BLOOD

microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma

(2010) J.-J. Zhao et al.   BLOOD

microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival

(2010) S. Rossi et al.   BLOOD

MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity

(2010) Lei Shi et al.   BRAIN RESEARCH

Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases

(2010) Vlastimil Kulda et al.   CANCER GENETICS AND CYTOGENETICS

Anti-miR-21 oligonucleotide sensitizes leukemic K562 cells to arsenic trioxide by inducing apoptosis

(2010) Yumin Li et al.   CANCER SCIENCE

The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma

(2010) Feng Zhi et al.   EUROPEAN JOURNAL OF CANCER

Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line

(2010) Haitao Bai et al.   FEBS LETTERS

Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma

(2010) P. Kamper et al.   HAEMATOLOGICA

MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis

(2010) Wen Gao et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma

(2010) Pedro P. Medina et al.   NATURE

Targeting microRNAs in cancer: rationale, strategies and challenges

(2010) Ramiro Garzon et al.   NATURE REVIEWS DRUG DISCOVERY

Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma

(2010) Christian Steidl et al.   NEW ENGLAND JOURNAL OF MEDICINE

Negative regulation of the tumor suppressor p53 gene by microRNAs

(2010) M Kumar et al.   ONCOGENE

Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer

(2010) Jin-Hyeok Hwang et al.   PLoS One

Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma

(2009) A. Navarro et al.   BLOOD

Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell linesversusCD77+B-cells reveals a distinct subset of differentially expressed miRNAs

(2009) Pieter Van Vlierberghe et al.   BRITISH JOURNAL OF HAEMATOLOGY

A TaqMan Low-Density Array to Predict Outcome in Advanced Hodgkin's Lymphoma Using Paraffin-Embedded Samples

(2009) B. Sanchez-Espiridion et al.   CLINICAL CANCER RESEARCH

Amplification and Overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in Medulloblastoma

(2009) Yuan Lu et al.   PLoS One

Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome

(2008) B. Chetaille et al.   BLOOD

Tumor-Infiltrated Immune Response Correlates with Alterations in the Apoptotic and Cell Cycle Pathways in Hodgkin and Reed-Sternberg Cells

(2008) T. Alvaro et al.   CLINICAL CANCER RESEARCH

Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma

(2008) A. Tzankov et al.   HAEMATOLOGICA

Identification of metastasis-related microRNAs in hepatocellular carcinoma

(2008) Anuradha Budhu et al.   HEPATOLOGY

MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma

(2008) Yao-Tseng Chen et al.   MODERN PATHOLOGY